Investors Urged to Act on Class Action Deadlines for Hims & Hers and GoHealth
New York, Friday, 11 July 2025.
Rosen Law Firm advises investors of Hims & Hers and GoHealth to secure legal counsel before imminent deadlines. This move follows allegations affecting investor confidence and potential market impacts.
Hims & Hers Health, Inc. Under Legal Scrutiny
On July 10, 2025, the Rosen Law Firm, a leader in investor rights litigation, urged stakeholders in Hims & Hers Health, Inc. (NYSE: HIMS) to act promptly by securing legal representation before the critical deadline of August 25, 2025. This advisory comes amidst ongoing investigations into alleged securities violations linked to misleading statements about the company’s collaboration with Novo Nordisk A/S concerning the weight-loss drug Wegovy. Investor confidence is potentially at stake due to the revelations of undisclosed agreements and the planned expansion of product offerings, which were not initially made clear to shareholders [1].
Implications for Hims & Hers Investors
The lawsuit highlights that Hims & Hers is accused of failing to disclose vital details about its dealings with Novo Nordisk, meant to secure sustained access to Wegovy and semaglutide products under a personalization policy. These undisclosed communications have reportedly led to alleged investor losses once the accurate details surfaced in the market [1]. As investors face the impending court proceedings, it is crucial to understand that no class has yet been certified — meaning individual stakeholders must opt-in to be represented by counsel [1].
GoHealth, Inc. Faces Allegations
Similarly, GoHealth, Inc. (NASDAQ: GOCO) is under the microscope due to claims of providing misleading business information that resulted in significant financial losses for investors. The potential legal actions stem from accusations that, between 2016 and 2021, insurers under GoHealth illegitimately compensated brokers with substantial kickbacks for Medicare Advantage enrollments [2]. This practice is under investigation as it contravenes established insurance regulations, potentially damaging GoHealth’s market standing and investor trust.
Investor Actions and Market Impact
The unfolding scenarios for both Hims & Hers and GoHealth highlight the critical importance of investor awareness and proactive legal engagement. Investors are advised to weigh their options carefully and consider joining the class actions to safeguard their financial interests. With ongoing investigations and litigation in progress, these companies’ perceived market valuations might undergo transformation, contingent upon future courtroom determinations [1][2].